HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daisuke Aoki Selected Research

Serous Cystadenocarcinoma

1/2015Expression of sulfatide and sulfated lactosylceramide among histological types of human ovarian carcinomas.
11/2010Expression of α2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daisuke Aoki Research Topics

Disease

121Neoplasms (Cancer)
10/2022 - 02/2003
67Endometrial Neoplasms (Endometrial Cancer)
02/2022 - 03/2002
58Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 08/2003
40Uterine Cervical Neoplasms (Cancer of the Cervix)
09/2022 - 03/2005
30Carcinoma (Carcinomatosis)
01/2022 - 09/2004
20Ovarian Epithelial Carcinoma
11/2021 - 09/2004
16Clear Cell Adenocarcinoma
02/2016 - 06/2003
15Infertility (Sterility)
06/2022 - 11/2011
12Carcinogenesis
11/2017 - 12/2006
9Neoplasm Metastasis (Metastasis)
12/2019 - 01/2005
9Adenocarcinoma
10/2014 - 02/2003
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
09/2022 - 03/2005
8Microsatellite Instability
02/2022 - 11/2003
8Endometrioid Carcinoma
10/2020 - 03/2007
8Uterine Cervical Dysplasia
01/2019 - 12/2008
6Infections
08/2021 - 10/2017
6Breast Neoplasms (Breast Cancer)
04/2021 - 05/2013
6Lymphatic Metastasis
01/2021 - 02/2003
6Carcinosarcoma
10/2020 - 02/2003
6Endometrial Hyperplasia
07/2020 - 03/2006
6Endometriosis
12/2016 - 07/2006
5Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
02/2022 - 01/2012
4Dyslipidemias (Dyslipidemia)
01/2022 - 11/2013
4Mucinous Adenocarcinoma (Mucinous Carcinoma)
10/2020 - 03/2007
4Sarcoma (Soft Tissue Sarcoma)
01/2020 - 05/2012
4Squamous Intraepithelial Lesions
09/2019 - 02/2015
4Reperfusion Injury
10/2018 - 09/2016
3Disease Progression
10/2022 - 11/2017
3Neutropenia
11/2021 - 03/2011
3Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 09/2012
3Septic Shock (Toxic Shock Syndrome)
08/2021 - 01/2014
3Residual Neoplasm
11/2020 - 02/2016
3Teratoma (Teratoid Tumor)
10/2020 - 01/2007
3Choriocarcinoma
01/2020 - 09/2011
2Fistula
09/2022 - 01/2021
2Female Genital Diseases
01/2022 - 01/2012

Drug/Important Bio-Agent (IBA)

34Biomarkers (Surrogate Marker)IBA
02/2022 - 11/2009
25Paclitaxel (Taxol)FDA LinkGeneric
02/2022 - 09/2004
24Proteins (Proteins, Gene)FDA Link
06/2020 - 08/2004
22Pharmaceutical PreparationsIBA
01/2022 - 01/2007
22DNA (Deoxyribonucleic Acid)IBA
01/2022 - 06/2003
21Cisplatin (Platino)FDA LinkGeneric
11/2020 - 09/2004
14Carboplatin (JM8)FDA LinkGeneric
02/2022 - 01/2007
14Biological ProductsIBA
01/2020 - 06/2003
13MicroRNAs (MicroRNA)IBA
11/2020 - 11/2010
11PlatinumIBA
10/2022 - 11/2008
10Monoclonal AntibodiesIBA
11/2020 - 10/2004
7Estrogens (Estrogen)FDA Link
04/2021 - 03/2011
7Tumor Biomarkers (Tumor Markers)IBA
01/2020 - 10/2004
6AntigensIBA
02/2021 - 03/2005
6Irinotecan (Camptosar)FDA LinkGeneric
11/2020 - 02/2010
6AcidsIBA
07/2020 - 09/2004
6GlycolipidsIBA
10/2019 - 11/2010
5Bevacizumab (Avastin)FDA Link
09/2022 - 01/2021
5liposomal doxorubicin (Doxil)FDA Link
11/2021 - 11/2008
5Immune Checkpoint InhibitorsIBA
05/2021 - 11/2019
5Indicators and Reagents (Reagents)IBA
11/2020 - 11/2009
5Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2020 - 01/2016
5taxaneIBA
06/2019 - 02/2009
5Antineoplastic Agents (Antineoplastics)IBA
09/2017 - 09/2004
5Hormones (Hormone)IBA
10/2015 - 05/2012
5Small Interfering RNA (siRNA)IBA
04/2015 - 09/2006
5EnzymesIBA
01/2014 - 08/2003
4Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 09/2017
4LigandsIBA
02/2021 - 01/2015
4Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 05/2012
4Metformin (Glucophage)FDA LinkGeneric
01/2019 - 03/2013
4Polysaccharides (Glycans)IBA
01/2019 - 10/2007
4Messenger RNA (mRNA)IBA
02/2018 - 01/2006
3olaparibIBA
10/2022 - 01/2016
3Aurora KinasesIBA
01/2022 - 05/2013
31-dodecylpyridoxal (PLD)IBA
11/2021 - 11/2008
3Transcription Factors (Transcription Factor)IBA
09/2021 - 02/2017
3SteroidsIBA
08/2021 - 05/2006
3Coloring Agents (Dyes)IBA
05/2021 - 03/2016
32- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
11/2020 - 01/2012
3Docetaxel (Taxotere)FDA Link
06/2019 - 02/2009
3Progestins (Progestagens)IBA
03/2013 - 05/2012
3GalactosyltransferasesIBA
07/2010 - 08/2003
2pembrolizumabIBA
02/2022 - 04/2020

Therapy/Procedure

60Therapeutics
10/2022 - 02/2003
41Drug Therapy (Chemotherapy)
01/2022 - 02/2003
17Transplantation
06/2022 - 11/2011
16Hysterectomy
08/2022 - 02/2003
13Lymph Node Excision (Lymph Node Dissection)
08/2022 - 10/2009
9Radiotherapy
09/2022 - 03/2013
9Salpingo-oophorectomy
01/2022 - 05/2007
7Chemoradiotherapy
08/2021 - 06/2015
6Trachelectomy
01/2019 - 10/2009
5Neoadjuvant Therapy
02/2022 - 04/2016
4Laparotomy
08/2022 - 03/2005
4Aftercare (After-Treatment)
02/2022 - 04/2015
4Operative Surgical Procedures
01/2021 - 05/2007
4Adjuvant Chemotherapy
12/2019 - 01/2007
3Ovariectomy (Oophorectomy)
08/2022 - 02/2003
3Lasers (Laser)
01/2022 - 01/2014
3Immunotherapy
05/2021 - 09/2019
3Combination Drug Therapy (Combination Chemotherapy)
07/2018 - 05/2015
3Warm Ischemia
12/2017 - 09/2016
2Minimally Invasive Surgical Procedures
12/2021 - 10/2021